Deakin University
Browse

Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine

Version 2 2024-06-13, 08:51
Version 1 2014-10-28, 10:40
journal contribution
posted on 2024-06-13, 08:51 authored by J Lofland, S Kim, A Batenhorst, N Johnson, M Chatterton, R Cady, R Kaniecki, D Nash
Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine

History

Journal

Mayo Clinic proceedings

Volume

76

Pagination

1093-1101

Location

New York, N. Y.

ISSN

0025-6196

eISSN

1942-5546

Language

eng

Publication classification

C1.1 Refereed article in a scholarly journal

Copyright notice

2001, Elsevier

Issue

11

Publisher

Elsevier

Publication URL

Usage metrics

    Research Publications

    Categories

    No categories selected

    Keywords

    sumatriptan therapyacute migrainecost-effectivenesscost-benefit119999 Medical and Health Sciences not elsewhere classified970111 Expanding Knowledge in the Medical and Health Sciences

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC